SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-515190
Filing Date
2016-03-23
Accepted
2016-03-23 17:16:30
Documents
3
Period of Report
2016-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d165376d8k.htm 8-K 14448
2 EX-99.1 d165376dex991.htm EX-99.1 4423
3 GRAPHIC g165376g0323214638096.jpg GRAPHIC 3109
  Complete submission text file 0001193125-16-515190.txt   24743
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 161524641
SIC: 2834 Pharmaceutical Preparations